Pregnancy Category: C
ClassificationTherapeutic: anti infectives
Treatment of bacterial conjunctivitis.
Inhibits bacterial DNA synthesis by inhibiting DNA gyrase.
Death of susceptible bacteria with decreased symptoms and sequelae of bacterial conjunctivitis.Active against CDC coryneform group G, Corynebacterium pseudodiphtheriticum, Corynebacterium striatum, Haemophilus influenzae, Moraxella lacunata, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus hominis, Staphylococcus lugdunensis, Streptococcus mitis group, Streptococcus oralis, Streptococcus pneumoniae and Streptococcus salivarius.
Absorption: Minimal absorption follows ophthalmic use.
Metabolism and Excretion: Unknown.
Half-life: 7 hr.
Contraindicated in: Contact lens use.
Use Cautiously in: Obstetric: Use during pregnancy only if potential benefit justifies potential risk to fetus; Lactation: Use cautiously during lactation; Pediatric: Safe use in children <1 yr not established.
Adverse Reactions/Side Effects
Central nervous system
Ear, Eye, Nose, Throat
- conjunctival redness (most frequent)
- blurred vision
- eye irritation
- eye pain,
- eye pruritus.
Drug-Drug interactionNone noted.
Ophthalmic (Adults and Children ≥1 yr) One drop in affected eye(s) three times daily (4–12 h apart) for 7 days.
Ophthalmic suspension: 0.6% 5 mL in 7.5 mL bottle
- Assess eye for signs of infection (swelling, redness, pain, discharge) prior to and periodically during therapy.
Potential Nursing DiagnosesRisk for infection (Indications)
- Ophthalmic: Invert closed bottle and shake once before use. Remove cap with bottle still inverted. Tilt head back and, with bottle inverted, gently squeeze bottle to instill 1 drop in affected eye 3 times daily (4–12 hrs apart) for 7 days.
- Instruct patient to use besifloxacin as directed, even if feeling better. Do not skip doses or stop therapy early; may lead to decreased effectiveness and resistant infections. Avoid touching applicator to eye, finger, or other areas; may contaminate. Wash hands prior to instillation.
- Caution patient to avoid wearing contact lenses during therapy.
- Advise patient to discontinue immediately and notify health care professional if signs or rash or allergic reaction (hives, difficulty breathing, swelling of throat) occur.
- Resolution of signs and symptoms of infection.
Drug Guide, © 2015 Farlex and Partners